SHARE PRICE > View All Stock Detailed Share Information Latest News Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going Molecular Partners Announces Pricing of $20 Million Underwritten Offering > View All News All News Upcoming Events More events are coming soon. > View All Events All Events Latest Presentation October 31, 2024 Corporate Presentation - October 2024 August 26, 2024 Corporate Presentation - Half-Year 2024 Earnings Call June 14, 2024 Corporate Presentation - June 2024 > View All Presentations All Presentations Latest Financial Documents August 26, 2024 H1 2024 Business Update and Financial Statements May 16, 2024 Q1 2024 Financial Statement April 18, 2024 Molecular Partners statement regarding Passive Foreign Investment Company status > View All Reports All Annual Report Seth Lewis, SVP Investor Relations and Strategy Contact Seth STAY INFORMED Subscribe to email alerts of your choosing SUBSCRIBE Institutional investors: REQUEST 1-1 / CALL powered by schedulR
Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition
Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going
